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was to evaluate the anxiolytic-like effects of phytol in animal models to clarify their
possible action mechanism. After acute intraperitoneal treatment with phytol at doses
of 25, 50 and 75 mg/kg behavioral models of open-ﬁeld, elevated-plus-maze, rota-rod,
light–dark, marble-burying and pentobarbital sleeping time tests were utilized. In open
ﬁeld test, phytol (25, 50 and 75 mg/kg) [po0.01] increased the number of crossings and
rearings. However, the number of groomings [po0.01] was reduced. Likewise, the number
of entries and the time spent in light space were increased [po0.01] while the number of
marble-burying was decreased [po0.001], in elevated-plus-maze, light–dark and marble-
burying tests, respectively. In motor activity test, phytol (75 mg/kg) impaired the rota-rod
performance of mice [po0.01]. In pentobarbital sleeping time test, phytol 75 mg/kg
decreased for latency of sleeping and phytol (25, 50 and 75 mg/kg) increased the sleep
time when compared to negative control [po0.05]. All these effects were reversed by pre-
treatment with ﬂumazenil (2.5 mg/kg, i.p.), similarly to those observed with diazepam
(2 mg/kg, i.p.; positive control) suggesting that the phytol presents mechanism of action by
interaction with the GABAergic system. These ﬁndings suggest that acute administration
of phytol exerts an anxiolytic-like effect on mice. Furthermore, suppose that phytol
interacts with GABAA receptor, probably at the receptor subtypes that mediate benzodia-
zepines effects, to produce sedative and anxiolytic activities.
Published by Elsevier B.V.lsevier B.V.
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Fig. 1 – Chemical structure of phytol (3,7,11,15-
tetramethylhexadec-2-en-1-ol).
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Anxiety is generally a normal reaction to stress and there will
always be situations that create stress and discomfort
(Higgins and George, 2010; Mackenzie et al., 2011). There are
several different types of anxiety disorders. Benzodiazepines
(BDZ) are the ﬁrst-line pharmacological anxiolytics drugs, and
more psychoactive medications are being developed in the
last 45 year. However, despite the clinical efﬁcacy, most drugs
in this class have many problems, including sedation, muscle
relaxation, anterograde amnesia and risk of accidents (Mitte
et al., 2005; Cunningham et al., 2010). In addition, chronic
drug use can lead to psychomotor effects, paradoxical reac-
tions, tolerance, teratologic risk and dependence (Dell’osso
and Lader, 2013).
Although conventional anxiolytics have been used for
treatment of anxiety disorders, recent clinical evidences have
shown that selective serotonin reuptake inhibitors (SSRIs) are
also effective on various anxiety disorders. They act by
preventing the reuptake of 5-hydroxytryptamine (5-HT),
thereby increasing 5-HT levels within the synaptic cleft and
modulating neurochemical signaling (Nishikawa et al., 2007;
Tsapakis et al., 2012). However, paradoxically they may
increase symptoms of anxiety when treatment is initiated
and despite extensive research over the past 30 years focused
on SSRIs treatment, the precise mechanisms by which SSRIs
exert these opposing acute and chronic effects on anxiety
remain unknown (Burghardt and Bauer, 2013). Some clinical
studies have reported adverse outcomes, such as premature
birth, neonatal cardiovascular abnormalities, reduced bone
mineral density and an increased risk of bone fracture (Haney
et al., 2010; Olivier et al., 2011).
Given the side effects of BDZ and reuptake inhibitors,
numerous research groups are looking for new forms of
pharmacological treatment for anxiety that can replace the
conventional ones. In addition, the search for new com-
pounds which are more effective and safer, with less possi-
bility of adverse reactions is extremely necessary as a large
number of users become dependent on chemical and physi-
cal conditions. Thus, numerous scientiﬁc researchers have
been exploring for example several species of medicinal
plants both in terms of chemical and pharmacological com-
pounds in search for new anxiolytics (Brito et al., 2012
Oyemitan et al., 2013).
Several studies have shown that many plants containing
essential oil possess medicinal properties. Recent research
shows that the vast majority of biological activities are derived
from terpenes, which are the main chemical components in
these oils essential (Souto-Maior et al., 2011; Melo et al., 2013;
Russo et al., 2013). Previous studies have shown that terpenes
can affect the Central Nervous System (Guimarães et al., 2010;
Sousa, 2011; Machado et al., 2013).
The diterpene phytol (3,7,11,15-tetrametilhexadec-2-en-1-ol)
(Fig. 1) is a member of branched-chain unsaturated alcohols
whose common characteristic structural elements are one
hydroxyl group per molecule and a twenty-one double bond
carbon atoms (C20H40O), molecular weight 296.54 mol/L. It is
liquid at room temperature, with a density of 0.8533 g/cm3,
colorless with a boiling point of 202 1C, ﬂash point4200 1C andrefractive index 1.460–1.466. It is optically active inasmuch as it
contains three asymmetric carbon atoms. The aqueous solubi-
lity of phytol is about 0.00327mg/L (Belsito et al., 2010; McGinty
et al., 2010; Karunagoda, 2010). This compound is particularly
interesting because it is a component of the chlorophyll
molecule, present in green leaves of various medicinal plants,
hence it is present in nature in abundance (Rontani and
Volkman, 2003). However, phytol has not yet been submitted
to neuropharmacological evaluation.
Thus, to pursuit the development and introduction of new
drugs with greater efﬁcacy and safety is essential to enhance
treatment of anxiety. Importantly, the search for alternatives
with less toxicity has resulted in decreased introduction of
synthetic substances, which underscores the importance of
pharmacological studies of natural products such as phytol.
In this perspective, in view of its abundance and few data in
neuropharmacological literature, the aim of study was eval-
uate the anxiolytic-like effects of phytol in animal models to
clarify their possible action mechanism.2. Results
2.1. Open-ﬁeld test
Phytol (PHY), at doses 25, 50 and 75 mg/kg, (i.p.) showed
sedative effects as assessed by open-ﬁeld test in mice.
Signiﬁcant effects were detected with doses tested of PHY,
which produced similar percentages of increased number of
crossings (71%, 70% and 69.5%) and rearings (70%, 70%
and 71%) when compared with to positive control [po0.01].
The number of groomings (41%, 43% and 48% respectively)
[po0.01] were reduced with PHY 25, 50 and 75 mg/kg, whose
results were similar to those observed with diazepam (2 mg/
kg, i.p.), used as a positive controls [po0.01]. Flumazenil was
used for evaluating the possible mechanism of action of the
sedative effect of phytol. The group receiving ﬂumazenil
(2.5 mg/kg, i.p.) and PHY (75 mg/kg, i.p.) exhibited similar
behaviors to those from the positive control [po0.01], indicat-
ing that phytol produced a benzodiazepine-type sedative
effect (Table 1).
2.2. Motor coordination test (rota-rod test)
The rota-rod test was used for evaluating motor coordination
and presence of any muscle relaxation effect. Results showed
that there was no change after PHY administration (25 and
50 mg/kg, i.p.), when compared with to positive control
[po0.01]. PHY (75 mg/kg, i.p.) and diazepam signiﬁcantly
impaired the rota-rod performance of mice. PHY 75 mg/kg
and diazepam 2mg/kg reduced the take-time to fall-down
(63% and 66%, respectively) [po0.01]. Flumazenil was used
for evaluating the possible mechanism of action of muscle
Table 1 – Effects and action mechanism of phytol in open ﬁeld test.
Groups Number of squares crossed Number of grooming Number of rearing
Vehicle 49.1372.56 2.6770.44 35.1771.85
DZP 2 28.1372.36a 4.4470.41a 13.1370.93a
PHY 25 48.0971.65b 2.7570.42b 34.7070.69b
PHY 50 49.1871.81b 2.6270.16b 35.3571.92b
PHY 75 50.2571.88b 2.4270.26b 36.0371.69b
FLU 2.5þDZP 2 49.9771.20b 2.5770.88b 36.0971.41b
FLU 2.5 50.7570.71 2.2770.52 34.7871.09
FLU 2.5þPHY 75 49.2072.75 2.8070.37 38.4071.11
a po0.01, signiﬁcantly different from control group (vehicle).
b po0.01, signiﬁcantly different from DZP group (ANOVA followed by t-Student–Neuman–Keuls test as post-hoc test). PHY: phytol; DZP:
diazepam; and FLU: ﬂumazenil; values are the mean7S.E.M. (n¼7).
Table 2 – Effects and action mechanism of phytol in the
rota-rod test.
Groups Number of falls Time of permanence (s)
Vehicle 1.4070.25 178.770.56
DZP 2 2.8970.47a 165.071.38a
PHY 25 1.4570.47b 178.971.62b
PHY 50 1.4370.63b 178.671.80b
PHY 75 1.4770.33b 179.171.72b
FLU 2.5þDZP 2 1.4570.33 178.370.67
FLU 2.5 1.4870.16 178.570.65
FLU 2.5þPHY 75 1.4470.51 178.571.20
a po0.01, signiﬁcantly different from control group (vehicle).
b po0.01, signiﬁcantly different from DZP group (ANOVA followed
by t-Student–Neuman–Keuls test as post-hoc test). PHY: phytol;
DZP: diazepam; and FLU: ﬂumazenil; values are the mean7S.E.
M. (n¼7).
Table 3 – Effects and action mechanism of phytol on the
elevated-plus-maze test.
Groups NEOA TPOA
Vehicle 10.6770.74 122.576.37
DZP 2 15.7170.28a 208.473.57a
PHY 25 15.6770.65a 203.377.58a
PHY 50 15.7770.74a 209.372.00a
PHY 75 17.9770.47a,b,c,d 280.472.05a,b,c,d
FLU 2.5þDZP 2 10.7170.82b 126.171.31b
FLU 2.5 10.7270.43 122.671.28
FLU 2.5þPHY 75 10.6370.66e 121.874.67e
a po0.01, signiﬁcantly different from control group (vehicle).
b po0.01, signiﬁcantly different from DZP group.
c po0.01, signiﬁcantly different from PHY 25 group.
d po0.01, signiﬁcantly different from PHY 50 group.
e po0.01, signiﬁcantly different from PHY 75 group (ANOVA
followed by t-Student–Neuman–Keuls test as post-hoc test). PHY:
phytol; DZP: diazepam; FLU: ﬂumazenil; NEOA: number of entries
in the open arms; and TPOA: time of permanence in the open
arms; values are the mean7S.E.M. (n¼7).
b r a i n r e s e a r c h 1 5 4 7 ( 2 0 1 4 ) 3 4 – 4 236relaxation effect of phytol. The group receiving ﬂumazenil
(2.5 mg/kg, i.p.) and PHY (75 mg/kg, i.p.) exhibited similar
behaviors relative to the controls, indicating that phytol
involves benzodiazepine receptors in muscle relaxant effect
(Table 2).2.3. Elevated-plus-maze test (EPM)
In elevated-plus-maze apparatus, used for evaluating anxio-
lytic-like effects, there was no change after PHY administra-
tion (25 and 50 mg/kg, i.p.), when compared with negative
control [po0.01]. Intraperitoneal administration of PHY
(75 mg/kg) signiﬁcantly increased the number of entries in
open arms (78%), the percentage of entries into open arms
(99%), the percentage of time spent in open arms (97%) and in
the time of permanence in open arms (80%) compared with
the negative control [po0.01]. These effects were similar to
those of diazepam 2 mg/kg [NEOA, po0.01; TPOA, po0.01;].
On the other hand, in order to determine whether the
anxiolytic-like effects of PHY are exerted via GABAergic
systems, PHY treated mice were subjected to a co-treatment
with ﬂumazenil, a benzodiazepine receptor antagonist. The
anxiolytic-like effect of PHY (75 mg/kg) was reversed by
ﬂumazenil (2.5 mg/kg) (Table 3).2.4. Light–dark box test
The administration of diazepam increased [po0.01] the time
spent by mice in the illuminated space. However, no changes
were found in number of entries into this place after treat-
ment with PHY at doses 25 and 50 mg/kg (i.p.) [p40.01].
In this model, the administration of PHY (25, 50 and 75mg/kg)
[po0.01] increased the time spent by mice in the illuminated
compartment (7%, 11% and 66%, respectively), when compared
with to negative control [po0.01]. This effect was dose depen-
dent and statistically different when compared with to negative
control [po0.01] (Table 4). The effects of PHY (75mg/kg) are
more potent that diazepam 2mg/kg [po0.01]. On the other
hand, in order to determine whether the effects of PHY on time
spent light space are exerted via GABAergic systems, PHY
(75mg/kg) as a co-treatment with ﬂumazenil (2.5 mg/kg).
The effect of PHY on time spent light space was abolished by
ﬂumazenil (Table 4).
2.5. Marble-burying test (MBT)
In order to further expand the evaluation of the PHY anxio-
lytic-like properties, this model was also added. The group
Table 4 – Effects and action mechanism of phytol on the
light–dark test.
Groups Time spent light space (s)
Vehicle 104.271.48
DZP 2 158.172.06a
PHY 25 156.272.12a
PHY 50 156.671.26a
PHY 75 179.871.31a,b,c,d
FLU 2.5þDZP 2 103.371.01b
FLU 2.5 106.570.65
FLU 2.5þPHY 75 105.871.51e
a po0.01, signiﬁcantly different from control group (vehicle).
b po0.01, signiﬁcantly different from DZP group.
c po0.01, signiﬁcantly different from PHY 25 group.
d po0.01, signiﬁcantly different from PHY 50 group.
e po0.01, signiﬁcantly different from PHY 75 group (ANOVA
followed by t-Student–Neuman–Keuls test as post-hoc test). PHY:
phytol; DZP: diazepam; and FLU: ﬂumazenil; values are the
mean7S.E.M. (n¼7).
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Fig. 2 – Number of marbles-buried (NMB) in the marble-
burying test (MBT). apo0.001, signiﬁcantly different from
control group (vehicle); bpo0.001, signiﬁcantly different from
DZP; cpo0.001, signiﬁcantly different from PHY 75 group
(ANOVA followed by t-Student–Neuman–Keuls test as post-
hoc test). PHY: phytol; DZP: diazepam; and FLU: ﬂumazenil;
values are the mean7S.E.M. (n¼7).
Table 5 – Effects and action mechanism of phytol on
pentobarbital sleeping time test in mice.
Groups Latency of sleeping (s) Sleeping time
(min)
Vehicle 261.13719.43 47.1374.56
DZP 2 157.69712.43a 68.0373.91a
PHY 25 259.32711.78 50.5674.45a
PHY 50 252.11713.46 51.8972.91a
PHY 75 178.27718.54a 56.2373.24a
FLU 2.5þDZP 2 260.89716.75b 47.8974.67b
FLU 2.5 262.674713.78 46.9973.67
FLU 2.5þPHY 75 263.76711.64c 48.0175.12c
a po0.05, signiﬁcantly different from negative control group
(vehicle).
b po0.05, signiﬁcantly different from DZP group.
c po0.05, signiﬁcantly different from PHY 75 group (ANOVA
followed by t-Student–Neuman–Keuls test as post-hoc test). PHY:
phytol; DZP: diazepam; and FLU: ﬂumazenil; values are the
mean7S.E.M (n¼7).
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marbles-buried (NMB) by 67% when compared with the
negative control [po0.001]. In this protocol, the administra-
tion of PHY 25, 50, 75 (i.p.) reduced NMB respectively by 71%,
73%, 80% when compared to negative control [po0.001],
which suggests a more potent anxiolytic-like effect by phytol
rather than diazepam 2 mg/kg (Fig. 2). In addition, the
PHY 75 mg/kg reduced NMB by 39% when compared to DZP
2 mg/kg [po0.001]. In the second protocol, in order to deter-
mine whether the anxiolytic-like effects of PHY are exerted
via GABAergic systems, PHY (75 mg/kg) was used as a co-
treatment with ﬂumazenil (2.5 mg/kg). FLU 2.5þDZP 2
decreased by 181% the effect of DZP 2 mg/kg on NMB
[po0.001] and FLU 2.5þPHY 75 reduced by 396% the effect of
PHY 75 mg/kg on NMB [po0.001] (Fig. 2).
2.6. Pentobarbital sleeping time
In pentobarbital sleeping time test, the administration of DZP
2mg/kg and PHY 75mg/kg (i.p.) decreased for latency of sleeping
respectively by 40% and 31%, when compared to negative control
[po0.05]. In order to determine whether the anxiolytic-like effects
of PHY are exerted via GABAergic systems, PHY (75mg/kg) was
used as a co-treatment with ﬂumazenil (2.5mg/kg). FLU 2.5þDZP
2 reduced by 65% the effect of DZP 2mg/kg on latency of sleeping
[po0.05] and FLU 2.5þPHY 75 reduced by 48% the effect of PHY
75mg/kg on latency of sleeping [po0.05] (Table 5). In addition,
DZP 2mg/kg and PHY (25, 50 and 75mg/kg, respectively)
increased the sleep time in 44, 7, 10 and 19%, respectively when
compared to negative control [po0.05], suggesting an enhanced
pentobarbital effect. FLU 2.5þDZP 2 decreased by 30% the effect
of DZP 2mg/kg on latency of sleeping [po0.05] and FLU 2.5þPHY
75 reduced by 15% the effect of PHY 75mg/kg on latency of
sleeping [po0.05] (Table 5).3. Discussion
Before starting the discussion of present study it is important
to consider that phytol was evaluated as their safety in mice.And according to these studies phytol can be considered
moderately toxic to rodents, which emphasizes the need for
this study, since this compound is present in a large amount
of medicinal plants it is used by the population due to their
anxiolytic properties (OECD, 2001; Costa et al., 2012a).
In addition, some studies have shown that this diterpene
has pharmacological properties such as antioxidant, antino-
ciceptive and anticonvulsant (Costa et al., 2012b; Santos et al.,
in press).
In the present research, the sedative and anxiolytic effects of
phytol were examined in animal models using tests such as
open-feld, elevated-plus-maze, rota-rod, light–dark, marble-
burying and pentobarbital sleeping time, which are classic
models for screening central nervous system activity and
providing information about anxiety, sedation andmyorelaxant
b r a i n r e s e a r c h 1 5 4 7 ( 2 0 1 4 ) 3 4 – 4 238activity (Baretta et al., 2012; Chioca et al., 2013). Our results
suggest that PHY reduces locomotor activity and has sedative
and anxiolytic effects on mice. Therefore, these activities were
investigated in order to provide information to determine the
mechanism of action of this diterpene and the possible adverse
effects arising from its use in anxiety therapy.
Phytol was ﬁrstly evaluated on open-ﬁeld test, which gives
a good indication of exploratory activity of animal. Diazepam
has been used as a standard anxiolytic and also has been
frequently employed in behavioral pharmacology as a refer-
ence compound for potentially anxiolytic-acting substances
(Gomes et al., 2010; Mizushige et al., 2013). In relation to
phytol in any doses, it produced muscle relaxation and
sedative effects similarly to diazepam as these parameters
were not decreased in comparison control. On the other
hand, when compared to diazepam increase on number of
crossings and rearings, the outcomes suggest fewer adverse
reactions. Probably, it seems that anxiolytic effect of phytol is
unrelated to a loss of motor coordination or to neuromus-
cular blockade; instead, it may be caused by central depres-
sant activity.
In the present work, a clear anxiolytic-like activity of
phytol has been observed. The elevated-plus-maze has been
frequently used to detect and evaluate anxiolytic/anxiogenic-
like properties of drugs. The frequency and time spent in open
arms is the major index of anxiety in plus-maze model, given
the fact that rodents are extremely aversive to an open area
(Almeida et al., 2012). Diazepam increases the number of
entries into the open arms and increase the time spent in the
open arms, demonstrating the characteristic anxiolytic effect
of BDZ compounds. In this test, phytol at all doses tested
increased the entries into and time spent in the open arms,
indicating an anxiolytic-like effect without motor impair-
ment. These results indicate that anxiolytic activity is com-
parable with that produced by diazepam. In order to elucidate
the mechanism of the anxiolytic effect of phytol, ﬂumazenil
was used, an antagonist of benzodiazepine drugs. The results
showed that the effect of phytol was reversed by the admin-
istration of ﬂumazenil, indicating the involvement of benzo-
diazepine receptors.
In the light–dark box test, anxiety is generated by the
conﬂict between the desire to explore and to retreat from
an unknown and well-illuminated space (Costa et al., 2011;
Lima et al., 2013). In case of light–dark test, this effect showed
a dose-dependent behavior, because it increased the resi-
dence time of the animal in box clear, conﬁrming the
anxiolytic effect of the compound. However, only at dose of
75 mg/kg phytol's effects are greater than diazepam's as it
increases the parameters in control, diazepam and other
doses of phytol. A phytol blocking promoted by ﬂumazenil
was also observed, suggesting that phytol can interact with
GABAA receptor subunits responsible to the anxiolytic action
similarly to DZP, since ﬂumazenil is a GABAA receptor
antagonist in benzodiazepine binding site that possesses
the ability to induce anxiety (Ishola et al., 2012).
Despite the good predictive validity of the elevated-plus-maze
and light–dark tests for anxiolytic-like drugs, the use of more
than one animal model of anxiety is recommended to avoid
false-positive results. The marble-burying was used to conﬁrm
the anxiolytic-like effect observed in the elevated-plus-maze andlight–dark tests. Marble-burying is used as an assay to infer
compulsive, anxietylike behavior and is widely used as a model
of obsessive–compulsive disorder (Cryan and Sweeney, 2011;
Kinsey et al., 2011). Phytol dose-dependently reduced number
of marbles-buried at all doses. producing anxiolytic effects better
than the positive control group, corroborating the anxiolytic-like
behavior previously observed in the other tests. Similarly, in the
group pre-treated with ﬂumazenil, it was found a phytol blocking
mediated by ﬂumazenil, suggesting that phytol can interact with
GABA receptor subunits, which is responsible for anxiolytic
actions of diazepam.
At the same time, however, typical GABA/benzodiazepine
receptor agonists, such as diazepam, have side effects includ-
ing muscle relaxation and depressive mood (Hertz et al.,
2006). Contrary to diazepam, that reduced the residence time
on rotating bar and increases the number of falls in rota-rod
test, indicating a muscle relaxant effect and increased incoor-
dination characteristic of benzodiazepine compounds, PHY
showed anxiolytic-like effects without affecting locomotor
activity at lower doses, probably because they do not interact
with the GABA receptor subunits responsible for these
adverse reactions of BDZ (Wang et al., 2008).
Sedative and anxiolytic drugs, such as BDZ, facilitate the
action of γ-amino-butyric acid (GABA) upon the GABAA
receptor (Sieghart and Sperk, 2002). The pentobarbital-
induced sleep test evaluated a possible sedative effect of
the compound. In this test, CNS depressant and sedative
drugs classically decrease the sleep latency and increase the
sleeping time (Carlini and Burgos, 1979; Galdino et al., 2012).
The present results showed that phytol at all doses tested
increased the sleep time and only the dose of 75 mg/kg
decreased for latency of sleeping, suggesting a possible
sedative effect. However, this effect was not corroborated in
the open-ﬁeld test in a signiﬁcant way, suggesting that phytol
possibly was able to potentiate the pentobarbital effects
showing its depressive potential, but it may not be able to
induce sedative effect itself in the doses tested.
In summary, our results suggest that acute administration
of phytol exerts an anxiolytic-like effect on mice. Further-
more, they support the idea that PHY interacts with the
GABAA receptor, probably at the receptor subtypes that
mediate benzodiazepines effects, to produce sedative and
anxiolytic activities. Additional studies with subcronic and
chronic administration, however, are needed to prove this
activity and fully clarify the mechanism of anxiolytic effect of
PHY. In this way, PHY could manifest these effects at doses
not showing either sedative activity, being thus potentially
useful in clinical practice.4. Experimental procedure
4.1. Animals
Swiss (Mus musculus) albino mice (25–30 g) of 2 months old
purchased from Central Animal House of the Federal University
of Piaui were used for the present study. The animals were
allowed free access to water and food (Purinas pellets) ad
libitum and were kept under controlled lighting (12 h dark/light
cycle) and temperature (2671 1C). Behavioral experiments were
b r a i n r e s e a r c h 1 5 4 7 ( 2 0 1 4 ) 3 4 – 4 2 39conducted from 08:00 to 10:00 am; and the animals were
monitored for one more hour after behavioral experiments.
Experimental protocols and procedures were approved by
Animal Experimentation Ethics Committee at the Federal Uni-
versity of Piaui (CEEA/UFPI #013/11).
4.2. Drug treatments
Phytol (PHY), natural compound isolated, was emulsiﬁed
with 0.05% Tween 80 (Sigma-USA) dissolved in 0.9% saline
solution. 30 min before the experiments animals were intra-
peritoneally treated with phytol at dosages of 25, 50 and
75 mg/kg. Negative control group was received vehicle (0.05%
Tween 80 in 0.9% saline) at the same volume (10 ml/kg)
administered by same route as treated groups. Sodium
pentobarbital (Cristália – Brazil)) was dissolved in 0.9% saline
solution. Diazepam (DZP) 2 mg/kg (Sigma Chem. Co., St. Louis,
MO, USA) and Flumazenil (FLU) 2.5 mg/kg (Sigma Chem. Co.,
St. Louis, MO, USA) were intraperitoneally injected into mice
after dissolution in distilled water, and used as standards.
4.3. Experimental protocol
The animals were tested during light period and observed in
a closed room with constant temperature (2671 1C) and
illuminated with 15 V weak red light. All tests were per-
formed in different days with distinct groups of animals.
4.4. Open-ﬁeld test
The open-ﬁeld area wasmade of acrylic glass (transparent walls
and black ﬂoor; 303015 cm3), and was divided into nine
squares of equal area. This apparatus was used to evaluate the
exploratory activity of animal during 5min according to the
model described (Archer, 1973; Almeida et al., 2012). The
animals (male albino mice) were divided into ﬁve groups of
seven animals per group. The ﬁrst group was treated with 0.05%
Tween 80 in 0.9% saline (i.p.); second group was treated with
diazepam (2mg/kg, i.p.); third, fourth and ﬁfth groups were
treated with phytol (25, 50 and 75mg/kg, i.p.), respectively. After
30min of treatment, the following parameters were monitored
during 5min; number of squares crossed with the four paws
(spontaneous locomotor activity), number of grooming behavior
(grooming) and number of surveys (rearing), not lean against
the wall. After each test, the equipment was washed with soap
and water, cleaned with ethanol 70% and dried.
To evaluate if anxiolytic of phytol were mediated by
GABA/benzodiazepine receptors on locomotor activity, three
groups of seven male mice were pretreated with ﬂumazenil
(2.5 mg/kg, i.p.), a recognized competitive antagonist on
central benzodiazepine receptor, 15 min after above treat-
ments, diazepam (2 mg/kg) and phytol (75 mg/kg) were admi-
nistrated to the groups of sixth and eighth respectively.
30 min later of the treatment, motor activity of animals was
veriﬁed similar to the protocol performed previously.
4.5. Motor coordination test (rota-rod test)
A rota-rod tread mill device was used for evaluation of motor
coordination and muscle relaxation produced by drugs inanimals (Shiotsuki et al., 2010). Male albino mice were divided
into ﬁve groups of seven mice per group. The ﬁrst and second
groups were treated with 0.05% Tween 80 in 0.9% saline and
dizepam (2 mg/kg, i.p.) respectively, third, fourth and ﬁfth
groups were treated with phytol at dosages of 25, 50 and
75 mg/kg (i.p.). Thirty minutes after administration of treat-
ments, mice were placed with the four paws on a 2.5 cm
diameter bar, 25 cm above the ﬂoor with a rotation of 17 rpm
for a period of 3 min for each animal. The time of perma-
nence on the bar and the number of falls were recorded with
triplicates at most. After each test, the equipment was
washed with soap and water, cleaned with ethanol 70% and
dried.
To evaluate if the effects of phytol were mediated by
GABA/benzodiazepine receptors on muscle relaxation three
groups of seven male mice in each were pretreated with
ﬂumazenil (2.5 mg/kg, i.p.), a recognized competitive antago-
nist at the central benzodiazepine receptor. 15 min after
ﬂumazenil treatment, diazepam (2 mg/kg) and phytol
(75 mg/kg) were administrated to groups of sixth and eighth
respectively. 30 min later, motor coordination and muscle
relaxation of animals were veriﬁed similar to the protocol
performed previously.
4.6. Elevated-plus-maze test (EPM)
The elevated-plus-maze test consists of two perpendicular
open arms (305 cm2) and two closed arms (30525 cm3)
in perpendicular position (Lister, 1987; Campelo et al., 2011).
The open and closed arms were connected by a central
platform (55 cm2). For this test ﬁve groups of ten animals
in each group were used. The ﬁrst group was treated with
vehicle (0.05% Tween 80 in 0.9% saline), the second group
with diazepam (2 mg/kg, i.p.) and the third, fourth and ﬁfth
groups were treated with phytol at doses of 25, 50, 75 mg/kg
(i.p.). Thirty minutes after administration of treatments, the
animal was placed at the center of the plus maze with its
nose in the direction of one of the closed arms, and observed
for 5 min to determine the following parameters – number of
entries in the open arms (NEOA), percentages of entries into
open arms (PEOA), time of permanence in open arms (TPOA)
and percentage of time of permanence in the open arms
(PTOA). After each test, the equipment was washed with soap
and water, cleaned with ethanol 70% and dried.
To evaluate if phytol effects were mediated by GABA/
benzodiazepine receptors three groups of seven male mice
per group were pretreated with ﬂumazenil (2.5 mg/kg, i.p.).
15 min after the above treatment, diazepam (2 mg/kg) and
phytol (75 mg/kg) were administrated to the groups of sixth
and eighth respectively. 30 min later of the treatment, the
parameters described of animals were veriﬁed similar to
protocol performed previously.
4.7. Ligh-dark box test
The light–dark test consisted of ﬁve groups of seven mice per
group. Treatment of mice was identical to the above tests.
30 min after treatment, the animals were placed in equip-
ment one at a time as described below. The apparatus used is
made of acrylic glass divided into two compartments (light
b r a i n r e s e a r c h 1 5 4 7 ( 2 0 1 4 ) 3 4 – 4 240box and dark box) that was communicated through a small
door (Crawley, 1981; Marques et al., 2013). The dark box (black
acrylic; 271829 cm3) is weakly lit. The clear box (trans-
parent acrylic; 271829 cm3) is illuminated by ambient
light. The ﬁrst and second groups were treated with 0.05%
Tween 80 in 0.9% saline and dizepam (2 mg/kg, i.p.) respec-
tively, third, fourth and ﬁfth groups were treated with phytol
at dosages of 25, 50 and 75 mg/kg (i.p.). Thirty minutes after
administration of treatments, the activities of each animal
were recorded for 5 min. The parameter used was the time
spent in light box in seconds. A compartment entry was
considered valid when the animal's four paws were inside
that chamber. After each test, the equipment was washed
with soap and water, cleaned with ethanol 70% and dried.
To evaluate if phytol effects were mediated by GABA/
benzodiazepine receptors three groups of seven male mice
per group were pretreated with ﬂumazenil (2.5 mg/kg, i.p.).
15 min after above treatment, diazepam (2 mg/kg) and phytol
(75 mg/kg) were administrated to the groups of sixth and
eighth respectively. 30 min later of the treatment, time spent
in light box of animals was recorded similar to the protocol
performed previously.
4.8. Marble-burying test (MBT)
The marble-burying procedure is based on a defensive burying
behavior that can be elicited in rodents in response to aversive
stimuli such as a shock prod, noxious food or an effective
unconditioned stimulus such as glass marbles (Poling et al.,
1981; Pires et al., 2013). The administration of a substance
likely to have anxiolytic effects in rodents tend to reduce the
number of marbles buried (NMB) in this test. The ﬁrst group
was treated with 0.05% Tween 80 (i.p.); second group was
treated with diazepam (2mg/kg, i.p.); third, fourth and ﬁfth
groups were treated with PHY (25, 50 and 75 mg/kg, i.p.),
respectively. Thirty minutes after treatments the animals were
placed individually in cages (27 long16 wide13 cm high)
with 25 glass marbles uniformly distributed on a 5 cm layer of
sawdust. The NMB in the sawdust was reported. A marble was
considered as hidden when it was at least two-thirds covered
by sawdust. After each test, the equipment was washed with
soap and water, cleaned with ethanol 70% and dried.
To evaluate if phytol effects were mediated by GABA/
benzodiazepine receptors three groups of seven male mice
per group were pretreated with ﬂumazenil (2.5 mg/kg, i.p.).
15 min after the above treatment, diazepam (2 mg/kg) and
phytol (75 mg/kg) were administrated to the groups of sixth
and eighth respectively. 30 min later of the treatment, number
of marbles buried of animals was veriﬁed similar to protocol
performed previously.
4.9. Pentobarbital sleeping time
Pentobarbital sodium was the test compound in evaluation of
pentobarbital induced sleeping time. The ﬁrst and second
groups were treated with 0.05% Tween 80 in 0.9% saline and
diazepam (2 mg/kg, i.p.) respectively, third, fourth and ﬁfth
groups were treated with PHY at dosages of 25, 50 and 75mg/kg
(i.p.). Sixty minutes after the administration of treatments the
animals received sodium pentobarbital (40 mg/kg, i.p.), and thetime elapsed between the administration of pentobarbital until
the loss of the righting reﬂex was recorded as the sleep latency,
and the time elapsed between the loss and voluntary recovery
of the righting reﬂex was recorded as the sleep time (Carlini and
Burgos, 1979).
To evaluate if phytol effects were mediated by GABA/
benzodiazepine receptors three groups of seven male mice
per group were pretreated with ﬂumazenil (2.5 mg/kg, i.p.).
15 min after above treatment, diazepam (2 mg/kg) and phytol
(75 mg/kg) were administrated to the groups of sixth and
eighth respectively. 30 min later of the treatment, the sleep
time of animals was veriﬁed similar to protocol performed
previously.4.10. Statistical analysis
All results are presented as mean7S.E.M. (standard error of
mean) values. The data were analyzed by means of analysis
of variance (ANOVA) followed by t-Student–Newman–Keuls's
as post-hoc test. Data were analyzed using the Graph Pad
Prism software (version 5.0) and experimental groups were
compared with the control positive The levels statistical
signiﬁcance ranged with po0.05, po0.01 and po0.001.Acknowledgments
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